These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1528344)

  • 21. Heat-induced inactivation mechanisms of Kunitz trypsin inhibitor and Bowman-Birk inhibitor in soymilk processing.
    Chen Y; Xu Z; Zhang C; Kong X; Hua Y
    Food Chem; 2014 Jul; 154():108-16. PubMed ID: 24518322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of the Bowman Birk protease inhibitor in mice following oral administration.
    Billings PC; St Clair WH; Maki PA; Kennedy AR
    Cancer Lett; 1992 Mar; 62(3):191-7. PubMed ID: 1596863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soybean bowman--birk inhibitor conjugates with clinical dextran. synthesis and antiproteolytic activity.
    Gladysheva IP; Moroz NA; Papisova AI; Larionova NI
    Biochemistry (Mosc); 2001 Apr; 66(4):384-9. PubMed ID: 11403644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bowman-Birk protease inhibitor and its palmitic acid conjugate prevent 7,12-dimethylbenz[a]anthracene-induced transformation in cultured mouse mammary glands.
    Du X; Beloussow K; Shen WC
    Cancer Lett; 2001 Mar; 164(2):135-41. PubMed ID: 11179827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor.
    Billings PC; Habres JM; Liao DC; Tuttle SW
    Cancer Res; 1991 Oct; 51(20):5539-43. PubMed ID: 1913672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of the soybean Bowman-Birk proteinase inhibitor and of its chymotrypsin and trypsin inhibiting fragments to bovine alpha-chymotrypsin and bovine beta-trypsin. A thermodynamic study.
    Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
    J Mol Recognit; 1990; 3(5-6):192-6. PubMed ID: 2096886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and characterization of soybean Bowman-Birk inhibitor from different sources.
    Gladysheva IP; Balabushevich NG; Moroz NA; Larionova NI
    Biochemistry (Mosc); 2000 Feb; 65(2):198-203. PubMed ID: 10713547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent.
    Ekrami H; Kennedy AR; Witschi H; Shen WC
    J Drug Target; 1993; 1(1):41-9. PubMed ID: 8069543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute effects of the Bowman-Birk protease inhibitor in mice.
    Oreffo VI; Billings PC; Kennedy AR; Witschi H
    Toxicology; 1991; 69(2):165-76. PubMed ID: 1949045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amelioration of gentamicin nephrotoxicity by phospholipids.
    Chan MK; Chan KW; Ng WL
    Nephrol Dial Transplant; 1991; 6(9):608-14. PubMed ID: 1745384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of Bowman-Birk protease inhibitor on autophagy in MDAMB231 breast cancer cell line.
    Kyani S; Akrami H; Mostafaei A; Akbari S; Salehi Z
    J Cancer Res Ther; 2021; 17(2):504-509. PubMed ID: 34121699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of N-nitrosomethylbenzylamine-induced esophageal neoplasms by the Bowman-Birk protease inhibitor.
    von Hofe E; Newberne PM; Kennedy AR
    Carcinogenesis; 1991 Nov; 12(11):2147-50. PubMed ID: 1934302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Internalisation of the Bowman-Birk protease inhibitor by intestinal epithelial cells.
    Billings PC; Brandon DL; Habres JM
    Eur J Cancer; 1991; 27(7):903-8. PubMed ID: 1834126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of poly (ADP-ribose) polymerase inhibition on aminoglycoside-induced acute tubular necrosis in rats.
    Biro A; Vaknine H; Cohen-Armon M; Matas Z; Fux A; Schreiber L; Berger E; Dan M; Boaz M; Gregoriev O; Katzir Z
    Clin Nephrol; 2016 Apr; 85(4):226-34. PubMed ID: 26951968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biodistribution of Bowman-Birk soybean protease inhibitor conjugate with amphiphilic polyester.
    Larionova NI; Gladysheva IP; Polekhina OV; Kurochkina LP; Gorbatova EN
    Appl Biochem Biotechnol; 1996; 61(1-2):139-48. PubMed ID: 9100351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiapoptotic activity of the Bowman-Birk inhibitor can be attributed to copurified phospholipids.
    Foehr MW; Tomei LD; Goddard JG; Pemberton PA; Bathurst IC
    Nutr Cancer; 1999; 34(2):199-205. PubMed ID: 10578488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary excretion of Bowman-Birk inhibitor in humans after soy consumption as determined by a monoclonal antibody-based immunoassay.
    Wan XS; Lu LJ; Anderson KE; Ware JH; Kennedy AR
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):741-7. PubMed ID: 10919746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
    Zhang L; Wan XS; Donahue JJ; Ware JH; Kennedy AR
    Nutr Cancer; 1999; 33(2):165-73. PubMed ID: 10368812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soybean-derived Bowman-Birk inhibitor inhibits neurotoxicity of LPS-activated macrophages.
    Li J; Ye L; Cook DR; Wang X; Liu J; Kolson DL; Persidsky Y; Ho WZ
    J Neuroinflammation; 2011 Feb; 8():15. PubMed ID: 21324129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteinase inhibition using small Bowman-Birk-type structures.
    Fernandez JH; Mello MO; Galgaro L; Tanaka AS; Silva-Filho MC; Neshich G
    Genet Mol Res; 2007 Oct; 6(4):846-58. PubMed ID: 18058707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.